Detalles de la búsqueda
1.
Integrative genomic and transcriptomic profiling reveals distinct molecular subsets in adult mixed phenotype acute leukemia.
Am J Hematol
; 98(1): 66-78, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36219502
2.
The CSN5/HSF/SPI1/PU.1 Axis Regulates Cell Proliferation in Hypocellular Myelodysplastic Syndrome Patients.
J Pediatr Hematol Oncol
; 45(7): e873-e878, 2023 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37526438
3.
Venetoclax with decitabine as frontline treatment in younger adults with newly diagnosed ELN adverse-risk AML.
Blood
; 142(15): 1323-1327, 2023 Oct 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37478399
4.
Effects of preemptive interferon-α monotherapy in acute leukemia patients with relapse tendency after allogeneic hematopoietic stem cell transplantation: a case-control study.
Ann Hematol
; 97(11): 2195-2204, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-29995264
5.
Rapid and deep response to avapritinib in heavily treated acute myeloid leukemia with t (8;21) and KIT mutation.
Ann Hematol
; 101(10): 2347-2350, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35767050
6.
Three times spontaneous remission of severe aplastic anemia following granulocyte transfusion from related donors: a case report and literature review.
Chin Med Sci J
; 28(1): 58-60, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23527810
7.
[The association of killer cell immunoglobulin like receptor gene polymorphism with cytomegalovirus infection after hematopoietic stem cell transplantation].
Zhonghua Nei Ke Za Zhi
; 52(2): 161-5, 2013 Feb.
Artículo
en Zh
| MEDLINE | ID: mdl-23967614
8.
[The variation and clinical significance of paroxysmal nocturnal hemoglobinuria clone in patients with aplastic anemia before and after immunosuppressive therapy].
Zhonghua Nei Ke Za Zhi
; 52(7): 585-9, 2013 Jul.
Artículo
en Zh
| MEDLINE | ID: mdl-24267002
9.
[Efficacies of hematopoietic stem cell transplantation plus imatinib in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia: a comparative study].
Zhonghua Yi Xue Za Zhi
; 93(8): 583-7, 2013 Feb 26.
Artículo
en Zh
| MEDLINE | ID: mdl-23663336
10.
[Clinical characteristics in adult acute myeloid leukemia with isocitrate dehydrogenase gene mutation].
Zhonghua Yi Xue Za Zhi
; 93(10): 751-5, 2013 Mar 12.
Artículo
en Zh
| MEDLINE | ID: mdl-23755812
11.
[Impact of induced therapy before allogeneic hematopoietic stem-cell transplantation for higher-risk myelodysplastic syndrome: experience of single centre].
Zhonghua Yi Xue Za Zhi
; 93(40): 3185-8, 2013 Oct 29.
Artículo
en Zh
| MEDLINE | ID: mdl-24405537
12.
[Changes of transcription factors Bcl-6, Foxp3 and RORγt in CD4(+) cells in bone marrow of immuno-related hematocytopenia].
Zhonghua Yi Xue Za Zhi
; 93(20): 1529-32, 2013 May 28.
Artículo
en Zh
| MEDLINE | ID: mdl-24028716
13.
[Retrospective analysis on therapeutic effect of autologous hematopoietic stem cell transplantation in multiple myeloma patients].
Zhonghua Yi Xue Za Zhi
; 93(2): 114-8, 2013 Jan 08.
Artículo
en Zh
| MEDLINE | ID: mdl-23648347
14.
[Lower risk myelodysplastic syndrome patients with transfusion dependent treated by dose-reduced decitabine].
Zhonghua Yi Xue Za Zhi
; 93(40): 3189-92, 2013 Oct 29.
Artículo
en Zh
| MEDLINE | ID: mdl-24405538
15.
Combination of venetoclax with BCR-ABL tyrosine kinase inhibitor as a therapeutic strategy for Philadelphia chromosome-positive leukemias.
Hematology
; 28(1): 2237790, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37477259
16.
Anti-CD19 CAR T-cell consolidation therapy combined with CD19+ feeding T cells and TKI for Ph+ acute lymphoblastic leukemia.
Blood Adv
; 7(17): 4913-4925, 2023 09 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36897251
17.
[Clinical efficacies and safety of HAG regimen for patients with high-risk myelodysplastic syndromes: a multicentre study].
Zhonghua Yi Xue Za Zhi
; 92(10): 689-91, 2012 Mar 13.
Artículo
en Zh
| MEDLINE | ID: mdl-22781297
18.
[Comparison of Therapeutic Efficacy between Hypomenthylating Agents Combined with Venetoclax and Half Dose Priming Regimen in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 30(6): 1631-1636, 2022 Dec.
Artículo
en Zh
| MEDLINE | ID: mdl-36476881
19.
Rapid and Efficient Response to Gilteritinib and Venetoclax-Based Therapy in Two AML Patients with FLT3-ITD Mutation Unresponsive to Venetoclax Plus Azacitidine.
Onco Targets Ther
; 15: 159-164, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35221695
20.
Investigation of the risk factors to predict cytokine release syndrome in relapsed or refractory B-cell acute lymphoblastic leukemia patients receiving IL-6 knocking down anti-CD19 chimeric antigen receptor T-cell therapy.
Front Immunol
; 13: 922212, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36105799